Chemoinformaics analysis of 2,3,5-Trimethyl-2-cyclopentenone
Molecular Weight | 124.183 | nRot | 0 |
Heavy Atom Molecular Weight | 112.087 | nRig | 6 |
Exact Molecular Weight | 124.089 | nRing | 1 |
Solubility: LogS | -1.892 | nHRing | 0 |
Solubility: LogP | 1.962 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 22.1635 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.482 |
Synth | 3.451 |
Natural Product Likeliness | 1.522 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0.007 |
HIA | 0.006 |
CACO-2 | -4.451 |
MDCK | 0.0000298 |
BBB | 0.545 |
PPB | 0.745567 |
VDSS | 1.323 |
FU | 0.3645 |
CYP1A2-inh | 0.691 |
CYP1A2-sub | 0.833 |
CYP2c19-inh | 0.31 |
CYP2c19-sub | 0.892 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.451 |
CYP2d6-inh | 0.243 |
CYP2d6-sub | 0.585 |
CYP3a4-inh | 0.027 |
CYP3a4-sub | 0.396 |
CL | 11.25 |
T12 | 0.689 |
hERG | 0.009 |
Ames | 0.02 |
ROA | 0.271 |
SkinSen | 0.163 |
Carcinogencity | 0.182 |
EI | 0.974 |
Respiratory | 0.162 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.950385 |